Microfluidics Reveal Tumor Immune Microenvironment Dynamics
Researchers at the Medical Research Center and School of Medicine, Southern University of Science and Technology report in Cancer Biology & Medicine that microfluidic platforms are emerging tools for modeling tumor–immune interactions, evaluating immunotherapy efficacy, and manufacturing therapeutic components. The review details chip-based models capturing macrophage migration, vascular intravasation/extravasation, immune-cell heterogeneity, and on-chip testing of CAR-T, TCR-T, NK cells, and checkpoint blockade. Authors urge better in vivo validation, clinical correlation, and higher-throughput systems for translation.
Key Points
- 1Demonstrate microfluidic chips model tumor–immune dynamics, including macrophage migration and vascular interactions
- 2Highlight heterogeneous immune-cell function and on-chip testing of CAR-T, TCR-T, NK, and checkpoint therapies
- 3Enable faster drug-screening, biomarker discovery, and personalized ex vivo testing using patient-derived tissues
Scoring Rationale
Comprehensive peer-reviewed review with broad translational relevance, but mainly synthesizes existing methods rather than novel experimental breakthroughs.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems